Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease.

Tang ZH, Liang S, Potter J, Jiang X, Mao HQ, Li Z.

J Immunol. 2013 Feb 15;190(4):1788-96. doi: 10.4049/jimmunol.1202814. Epub 2013 Jan 7.

2.

Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death.

Tang T, Sui Y, Lian M, Li Z, Hua J.

PLoS One. 2013 Dec 3;8(12):e81949. doi: 10.1371/journal.pone.0081949. eCollection 2013.

3.

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Liu Y, Ji H, Zhang Y, Shen X, Gao F, He X, Li GA, Busuttil RW, Kuchroo VK, Kupiec-Weglinski JW.

J Hepatol. 2015 Mar;62(3):563-72. doi: 10.1016/j.jhep.2014.10.034. Epub 2014 Oct 31.

4.

Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis.

Kremer M, Thomas E, Milton RJ, Perry AW, van Rooijen N, Wheeler MD, Zacks S, Fried M, Rippe RA, Hines IN.

Hepatology. 2010 Jan;51(1):130-41. doi: 10.1002/hep.23292.

5.

Probiotic antigens stimulate hepatic natural killer T cells.

Liang S, Webb T, Li Z.

Immunology. 2014 Feb;141(2):203-10. doi: 10.1111/imm.12180.

6.

The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.

Ju Y, Shang X, Liu Z, Zhang J, Li Y, Shen Y, Liu Y, Liu C, Liu B, Xu L, Wang Y, Zhang B, Zou J.

Mol Immunol. 2014 Mar;58(1):85-91. doi: 10.1016/j.molimm.2013.11.001. Epub 2013 Dec 10.

PMID:
24333756
7.

Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice.

Cui K, Yan G, Xu C, Chen Y, Wang J, Zhou R, Bai L, Lian Z, Wei H, Sun R, Tian Z.

J Hepatol. 2015 Jun;62(6):1311-8. doi: 10.1016/j.jhep.2014.12.027. Epub 2015 Jan 10.

PMID:
25582105
8.

Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.

Veenstra RG, Taylor PA, Zhou Q, Panoskaltsis-Mortari A, Hirashima M, Flynn R, Liu D, Anderson AC, Strom TB, Kuchroo VK, Blazar BR.

Blood. 2012 Jul 19;120(3):682-90. doi: 10.1182/blood-2011-10-387977. Epub 2012 Jun 7.

9.

NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.

Locatelli I, Sutti S, Vacchiano M, Bozzola C, Albano E.

Clin Sci (Lond). 2013 Feb;124(4):279-87. doi: 10.1042/CS20120289.

PMID:
22970906
10.

T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.

Uchida Y, Ke B, Freitas MC, Yagita H, Akiba H, Busuttil RW, Najafian N, Kupiec-Weglinski JW.

Gastroenterology. 2010 Dec;139(6):2195-206. doi: 10.1053/j.gastro.2010.07.003. Epub 2010 Jul 13.

11.

Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.

Hua J, Ma X, Webb T, Potter JJ, Oelke M, Li Z.

J Lipid Res. 2010 Jul;51(7):1696-703. doi: 10.1194/jlr.M003004. Epub 2010 Feb 24.

12.

NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.

Alhasson F, Dattaroy D, Das S, Chandrashekaran V, Seth RK, Schnellmann RG, Chatterjee S.

Am J Physiol Renal Physiol. 2016 Jan 1;310(1):F85-F101. doi: 10.1152/ajprenal.00243.2015. Epub 2015 Oct 7.

13.

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.

Ma X, Hua J, Li Z.

J Hepatol. 2008 Nov;49(5):821-30. doi: 10.1016/j.jhep.2008.05.025. Epub 2008 Jun 30.

14.

Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.

Dardalhon V, Anderson AC, Karman J, Apetoh L, Chandwaskar R, Lee DH, Cornejo M, Nishi N, Yamauchi A, Quintana FJ, Sobel RA, Hirashima M, Kuchroo VK.

J Immunol. 2010 Aug 1;185(3):1383-92. doi: 10.4049/jimmunol.0903275. Epub 2010 Jun 23.

15.

Galectin-9 prolongs the survival of septic mice by expanding Tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophages.

Kadowaki T, Morishita A, Niki T, Hara J, Sato M, Tani J, Miyoshi H, Yoneyama H, Masaki T, Hattori T, Matsukawa A, Hirashima M.

Crit Care. 2013 Dec 9;17(6):R284. doi: 10.1186/cc13147.

16.

Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.

Tang Y, Bian Z, Zhao L, Liu Y, Liang S, Wang Q, Han X, Peng Y, Chen X, Shen L, Qiu D, Li Z, Ma X.

Clin Exp Immunol. 2011 Nov;166(2):281-90. doi: 10.1111/j.1365-2249.2011.04471.x.

17.

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

Syn WK, Oo YH, Pereira TA, Karaca GF, Jung Y, Omenetti A, Witek RP, Choi SS, Guy CD, Fearing CM, Teaberry V, Pereira FE, Adams DH, Diehl AM.

Hepatology. 2010 Jun;51(6):1998-2007. doi: 10.1002/hep.23599.

18.

Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.

Kanzaki M, Wada J, Sugiyama K, Nakatsuka A, Teshigawara S, Murakami K, Inoue K, Terami T, Katayama A, Eguchi J, Akiba H, Yagita H, Makino H.

Endocrinology. 2012 Feb;153(2):612-20. doi: 10.1210/en.2011-1579. Epub 2011 Dec 20.

PMID:
22186414
19.

Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.

Li Z, Oben JA, Yang S, Lin H, Stafford EA, Soloski MJ, Thomas SA, Diehl AM.

Hepatology. 2004 Aug;40(2):434-41.

PMID:
15368448
20.

Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency.

Reddy PB, Sehrawat S, Suryawanshi A, Rajasagi NK, Mulik S, Hirashima M, Rouse BT.

J Immunol. 2011 Dec 1;187(11):5745-55. doi: 10.4049/jimmunol.1102105. Epub 2011 Oct 21.

Supplemental Content

Support Center